Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 1201 AL 1215

Pharmacological Potential of Bioactive Peptides for the Treatment of Diseases Associated with Alzheimer's and Brain Disorders

Gupta JK, Singh K.

Curr Mol Med. 2024;24(8):962-979. doi: 10.2174/1566524023666230907115753.

Role of BDNF Signaling in the Neuroprotective and Memory-enhancing Effects of Flavonoids in Alzheimer's Disease

Amidfar M, Garcez ML, Askari G, Bagherniya M, Khorvash F, Golpour-Hamedani S, de Oliveira J.

CNS Neurol Disord Drug Targets. 2024;23(8):984-995. doi: 10.2174/1871527323666230912090856.

Microbiota-Gut-Brain Axis Dysregulation in Alzheimer's Disease: Multi-Pathway Effects and Therapeutic Potential

Qu L, Li Y, Liu F, Fang Y, He J, Ma J, Xu T, Wang L, Lei P, Dong H, Jin L, Yang Q, Wu W, Sun D.

Aging Dis. 2024 May 7;15(3):1108-1131. doi: 10.14336/AD.2023.0823-2.

Improving Clinical Trials of Antioxidants in Alzheimer's Disease

Daly T.

J Alzheimers Dis. 2024;99(s1):S171-S181. doi: 10.3233/JAD-230308.

Microglia and Astrocytes in Alzheimer's Disease: Significance and Summary of Recent Advances

Deng Q, Wu C, Parker E, Liu TC, Duan R, Yang L.

Aging Dis. 2024 Aug 1;15(4):1537-1564. doi: 10.14336/AD.2023.0907.

Gamma Secretase as an Important Drug Target for Management of Alzheimer's Disease: A Comprehensive Review

Hakem FT, Fouad YF, Arafa RK.

Curr Top Med Chem. 2024;24(2):109-127. doi: 10.2174/0115680266259174231006070637.

Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease

Perluigi M, Di Domenico F, Butterfield DA.

Physiol Rev. 2024 Jan 1;104(1):103-197. doi: 10.1152/physrev.00030.2022.

Recent Advancements in the Treatment of Alzheimer's Disease: A Multitarget-directed Ligand Approach

Kumar S, Mahajan A, Ambatwar R, Khatik GL.

Curr Med Chem. 2024;31(37):6032-6062. doi: 10.2174/0109298673264076230921065945.

Potential Neuroprotective Strategies using Smart Drug Delivery Systems for Alzheimer's Disease

Khan J, Yadav S, Alam MA.

Infect Disord Drug Targets. 2024;24(3):e231023222565. doi: 10.2174/0118715265254985231012065058.

Microglia: Formidable Players in Alzheimer's Disease and Other Neurodegenerative Disorders

Maiese K.

Curr Neurovasc Res. 2024;20(5):515-518. doi: 10.2174/1567202620999231027155308.

γ-Secretase: once and future drug target for Alzheimer's disease

Wolfe MS.

Expert Opin Drug Discov. 2024 Jan-Jun;19(1):5-8. doi: 10.1080/17460441.2023.2277350. Epub 2024 Jan 8.

Arsenic Exposure and Amyloid Precursor Protein Processing: A Focus on Alzheimer's Disease

Sharma R, Abubakar MD, Bisht P, Rachamalla M, Kumar A, Murti K, Ravichandiran V, Kumar N.

Curr Mol Pharmacol. 2024;17:e18761429272806. doi: 10.2174/0118761429272806231020045840.

Research Mechanism and Progress of the Natural Compound Curcumin in Treating Alzheimer´s Disease

Li L, Wang F, Jia X, Yao L, Liu Y.

Mini Rev Med Chem. 2024;24(17):1590-1601. doi: 10.2174/0113895575263783231009051957.

Transdermal Therapeutic Systems for the Treatment of Alzheimer's Disease: A Patent Review

Basso L, Fagundes SC, Staudt T, da Rosa K, Langaro E, Omidian H, Bertol CD.

CNS Neurol Disord Drug Targets. 2024;23(9):1075-1084. doi: 10.2174/0118715273275957231102044934.

How Can We Use Mathematical Modeling of Amyloid-β in Alzheimer's Disease Research and Clinical Practices?

Chu C, Low YLC, Ma L, Wang Y, Cox T, Doré V, Masters CL, Goudey B, Jin L, Pan Y.

J Alzheimers Dis. 2024;97(1):89-100. doi: 10.3233/JAD-230938.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias